HER3 as Biomarker and Therapeutic Target in Pancreatic Cancer: New Insights in Pertuzumab Therapy in Preclinical Models
Oncotarget - United States
doi 10.18632/oncotarget.2231
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 18, 2014
Authors
Publisher
Impact Journals, LLC